The invention relates to an improved expansion culture medium for regulatory T cells of human
cord blood origin and an application method of the expansion culture medium. According to the expansion culture medium,
heparin anticoagulated autologous
cord blood plasma accounting for 10%-12% of the volume of a culture medium, CD3-CD28
antibody co-expressed immunomagnetic beads, recombinant human
interleukin 2, 2-mercaptoethanol, rapamycin,
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and
gentamicin are added into the RPMI (Roswell Park Memorial Institute)1640 culture medium; and then separated
cell suspension is inoculated in a 96-well plates with a U-shaped bottom, hole-division expansion can be performed every 1-2 days, and the expansion period is 3-4 weeks. All reagents in the culture
system reach the GMP (
good manufacturing practice) level or are originated from autologous
cord blood, so that risks caused by ingredients of
animal origin are avoided, and the regulatory T cells can be used for a third-party unrelated donor and directly applied to
clinical disease treatment; and compared with a traditional culture
system, Treg cells (the regulatory T cells) expanded by the improved culture medium is excellent in aspects of
growth speed, purity, activity,
lymphocyte inhibition function and the like, and the Treg cells are expected to be used as the regulatory T cells of the third-party unrelated donor and applied to the
clinical disease treatment.